Acadia Healthcare (NASDAQ:ACHC) Stock Price Expected to Rise, Barclays Analyst Says

Key Points

• Barclays raised its Acadia Healthcare price target from $32 to $35 but maintained an “equal weight” rating, implying about 1.47% upside from the prior close.
• Acadia beat third-quarter estimates, reporting EPS of $0.60 versus $0.46 expected and revenue of $895.3 million versus $877.8 million expected; revenue grew 5.1% year over year.
• The company raised its full-year 2026 guidance, though quarterly EPS was below the $0.72 reported a year earlier. Analyst opinions overall were mixed, with MarketBeat reporting a consensus “Hold” rating.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) had its price target increased by investment analysts at Barclays from $32.00 to $35.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's target price points to a potential upside of 1.47% from the company's previous close.

Several other research analysts have also issued reports on ACHC. TD Cowen increased their target price on Acadia Healthcare from $30.00 to $36.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Raymond James Financial lowered Acadia Healthcare from a "strong-buy" rating to an "outperform" rating and set a $39.00 price target on the stock. in a research report on Monday, September 28th. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Guggenheim boosted their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Finally, UBS Group increased their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 9th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Acadia Healthcare has a consensus rating of "Hold" and a consensus target price of $30.92.

Acadia Healthcare Price Performance

Acadia Healthcare stock traded up $2.24 during midday trading on Thursday, hitting $34.49. 2,749,026 shares of the company's stock were exchanged, compared to its average volume of 2,825,225. The company has a market cap of $3.21 billion, a P/E ratio of -2.75, a PEG ratio of 9.54 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a 50-day moving average price of $29.18 and a two-hundred day moving average price of $25.91. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $39.38.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.14. The company had revenue of $895.31 million for the quarter, compared to analysts' expectations of $877.76 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. Acadia Healthcare's revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the firm posted $0.72 EPS. On average, equities research analysts forecast that Acadia Healthcare will post 1.55 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $441,685,000. Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare during the 2nd quarter worth $106,458,000. First Trust Advisors LP raised its stake in Acadia Healthcare by 73.0% during the 1st quarter. First Trust Advisors LP now owns 1,689,442 shares of the company's stock worth $39,516,000 after acquiring an additional 712,852 shares in the last quarter. Deutsche Bank AG purchased a new stake in Acadia Healthcare in the second quarter valued at $49,746,000. Finally, Maverick Capital Ltd. lifted its position in Acadia Healthcare by 45.1% in the first quarter. Maverick Capital Ltd. now owns 1,314,116 shares of the company's stock valued at $30,737,000 after acquiring an additional 408,697 shares during the last quarter.

Acadia Healthcare News Roundup

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, above the $0.46 analyst consensus, while revenue of $895.3 million exceeded expectations of $877.8 million and grew 5.1% year over year. Zacks earnings report
• Positive Sentiment: The company raised its full-year 2026 financial guidance, a constructive signal about management’s expectations for performance. Same-facility revenue rose 5.2%, supported by a 1.1% increase in patient days and a 4.0% increase in revenue per patient day. Company results and guidance announcement
• Negative Sentiment: Despite beating estimates, quarterly EPS was below the $0.72 reported a year earlier, a sign that earnings remain under pressure compared with the prior-year period. Zacks earnings report

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia's services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.